Need professional-grade analysis? Visit stockanalysis.com
$26.27B
25.54
3,644
0.95%
Price Chart
Risk-Adjusted Performance
Xiamen Amoytop Biotech Co Ltd (688278) Price Performance
Xiamen Amoytop Biotech Co Ltd (688278) trades on SHG in CNY. The company is classified in the Healthcare sector under the Biotechnology industry. The stock currently trades at CNY63.16, down 2.23% from the previous close.
Over the past year, 688278 has traded between a low of CNY63.16 and a high of CNY91.33. The stock has lost 14.0% over this period. It is currently 30.8% below its 52-week high.
Xiamen Amoytop Biotech Co Ltd has a market capitalization of $26.27B, with a price-to-earnings ratio of 25.54 and a dividend yield of 0.95%.
About Xiamen Amoytop Biotech Co Ltd
Xiamen Amoytop Biotech Co., Ltd. engages in research, development, production, and sale of recombinant protein drugs in China and internationally. It offers various drug products, including pegsomatropin injection, pegfilgrastim injection, molgramostim, filgrastim, and oprelvekin; active pharmaceutical ingredients (APIs); and reagents to treat viral hepatitis, malignant tumors, and immunotherapy. Xiamen Amoytop Biotech Co., Ltd. was founded in 1996 and is headquartered in Xiamen, China.
Compare Xiamen Amoytop Biotech Co Ltd
Side-by-side comparison against top Healthcare peers.
Company Info
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- SHG
- Currency
- CNY
- Country
- China
Financial Metrics
- Revenue (TTM)
- $3.70B
- EBITDA
- $1.33B
- Profit Margin
- 27.91%
- EPS (TTM)
- 2.52
- Book Value
- 8.45
Technical Indicators
- 52 Week High
- CN¥93.52
- 52 Week Low
- CN¥61.65
- 50 Day MA
- CN¥69.06
- 200 Day MA
- CN¥77.47
- Beta
- -0.02
Valuation
- Trailing P/E
- 25.54
- Forward P/E
- N/A
- Price/Sales
- 7.11
- Price/Book
- 7.69
- Enterprise Value
- $25.69B